Trial Details
COMPLETEDBasic Information
| Clinical ID | c48 |
|---|---|
| Identifier | NCT07273760 |
| Trial Title | VedAryo® (Vedolizumab) Effectiveness and Safety Evaluation |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis (UC)|Crohn Disease (CD)|Inflammatory Bowel Disease (IBD) |
| Interventions | DRUG: Vedolizumab |
Participant Information
| Sponsor | AryoGen Pharmed Co. |
|---|---|
| City | Fars |
| Country/Region | Iran |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2023-07-16 |
|---|---|
| Primary Completion Date | 2025-09-30 |
| Completion Date | 2025-10-05 |